Fundz

Vaccinex, Inc. reported raising $13.8 Million in an initial SEC Form D filing, from an offering of $13.8 Million

PUBLIC · VCNXAug 14, 2019

Amount Raised

$13.8 Million

$13.8 Million sold, per SEC Form D (first sale Aug 14, 2019)

Round Type

Venture

City Of RochesterBiotechnologyHealthcareHealth CareTherapeutics

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Vaccinex that raised within 45 days of this round, from Fundz verified event records.

  • Renibus Therapeutics raised $3.4M on September 23, 2019.
  • Passage Bio raised $110M on September 6, 2019.
  • Werewolf Therapeutics raised $32M on August 15, 2019.
  • Recursion Pharmaceuticals raised $122M on August 13, 2019.
  • Chimerix raised $35M on July 31, 2019.
  • Solid Biosciences raised $60M on July 31, 2019.

Who to call at Vaccinex, and when

A new round usually means Vaccinex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vaccinex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vaccinex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vaccinex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vaccinex

Location

City Of Rochester, New York, United States

About

Vaccinex, Inc. is a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative diseases and cancer through the inhibition of semaphorin 4D (SEMA4D). The Company’s lead drug candidate, pepinemab, a SEMA4D blocking antibody, inhibits damaging inflammation and loss of homeostatic functions in the brain of patients with neurodegenerative diseases and promotes effective tumor immunity in multiple cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vaccinex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts57 people are listed at Vaccinex. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vaccinex's next move

See what Strategic adds

Vaccinex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.